プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Bailey A.に依頼

United States

Freelance Medical Writer with experience in oncology clinical development and precision medicine

プロフィール概要

Experienced primarily in the field of oncology (adult and pediatric), in both academia and industry.

専門分野

• ★ Medical Writing
• ☆ Genetics
• ☆ Drug Development
• ☆ Clinical Trials
• ☆ Clinical Trial Design
• ☆ Oncology
• ☆ Precision Medicine
• ☆ Pediatric Oncology
• ☆ Pediatric Hematology-Oncology
• ☆ Regulatory Writing
• ☆ Clinical Trial Documentation
• ☆ Technical & Scientific Writing
• ☆ Manuscript & Journal Article Writing
• ☆ Case Studies
• ☆ Literature Review

サービス

• Writing
• Research

Writing Clinical Trial Documentation, Technical Writing

Research Systematic Literature Review, Secondary Data Collection

職務経験

PRA Health Sciences

2020 - 現在

Eli Lilly and Co

7月 2018 - 2020

University of Michigan

3月 2016 - 7月 2018

学歴

University of Michigan

9月 2014 - 4月 2016

認定資格

• Certified Clinical Research Professional

  Society of Clinical Research Associates

  11月 2017 - 現在

出版物

JOURNAL ARTICLE

(2021). A phase 1b study of the Notch inhibitor crenigacestat (LY3039478) in combination with other anticancer target agents (taladegib, LY3023414, or abemaciclib) in patients with advanced or metastatic solid tumors . Investigational new drugs.

(2020). Accrual Trends for Children's Oncology Group Clinical Trials: A Single Center Experience . Journal of pediatric hematology/oncology.

(2020). Clinical Sequencing of High-Grade Undifferentiated Sarcomas: A Case Series and Report of an Aggressive Primary Cardiac Tumor With Multiple Oncogenic Drivers . JCO precision oncology.

(2020). Hepatosplenic αβ T-Cell Lymphoma as Second Malignancy in Young Adult Patient With Previously Undiagnosed Ataxia-Telangiectasia . Journal of pediatric hematology/oncology.

(2020). Mutations predictive of hyperactive Ras signaling correlate with inferior survival across high-risk pediatric acute leukemia . Translational pediatrics.

(2019). KRAS mutant tenosynovial giant cell tumor in a pediatric patient: a case report . Translational pediatrics.

(2019). Cryptic ETV6-ABL1 Fusion and MLL2 Truncation Revealed by Integrative Clinical Sequencing in Multiply Relapsed Acute Lymphoblastic Leukemia . Journal of pediatric hematology/oncology.

(2019). DICER1 Mutations in the Era of Expanding Integrative Clinical Sequencing in Pediatric Oncology . JCO precision oncology.

(2019). Refractory and metastatic infantile fibrosarcoma harboring LMNA-NTRK1 fusion shows complete and durable response to crizotinib . Cold Spring Harbor molecular case studies.

(2018). CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response . Acta neuropathologica communications.

(2018). Integration of Germline Pharmacogenetics Into a Tumor Sequencing Program . JCO precision oncology.

(2018). Exceptional Response to Cabozantinib in a Patient With Multiply Relapsed Wilms Tumor . JCO precision oncology.

(2018). Clinically Integrated Sequencing Alters Therapy in Children and Young Adults With High-Risk Glial Brain Tumors . JCO precision oncology.

(2018). Identification of novel MECOM gene fusion and personalized therapeutic targets through integrative clinical sequencing in secondary acute myeloid leukemia in a patient with severe congenital neutropenia: a case report and literature review . Cold Spring Harbor molecular case studies.

(2017). Blood-brain barrier-adapted precision medicine therapy for pediatric brain tumors . Translational research : the journal of laboratory and clinical medicine.